Department of Medicine Grand Rounds: An Immunotherapy Renaissance in Hepatobiliary Cancers

An Immunotherapy Renaissance in Hepatobiliary Cancers

Session moderated by Bob Wachter

Immunotherapy has revolutionized the way we treat many malignancies, including hepatobiliary cancers. In this Grand Rounds, UCSF Oncologists Robin Kate Kelley, MD and Bridget Keenan, MD, PhD, will discuss the newest developments in using immunotherapy to treat these cancers and their unique bench-to-bedside translational approach.  

Speakers
Robin Kate Kelley, MD, is a gastrointestinal oncologist who specializes in cancers arising from the liver, including hepatocellular carcinoma, bile duct cancer (cholangiocarcinoma), and gallbladder carcinoma. Her research interests include developing clinical trials of new treatments and combination therapies for these cancers, including immunotherapy approaches as well as translational research to identify molecular and genetic biomarkers of response.

Bridget Keenan, MD, PhD, is a physician-scientist who works in translational cancer research and medical oncology at the Cancer Immunotherapy Clinic, where she works with patients with solid organ cancers who are being treated on early phase immunotherapy trials. She studies the mechanisms of response and resistance to immunotherapy, with a focus on gastrointestinal cancers. 

How to Attend
In Person:
N-217 (Nursing Building, enter through 521 Parnassus Avenue.)
Lunch will be provided.

On Zoom:
Join from a PC, Mac, iPad, iPhone or Android device:
https://ucsf.zoom.us/j/93868706312?pwd=ZWpzeHlNYmJzcUp3c1JxRWpyTGF2QT09
Webinar ID: 938 6870 6312
Passcode: 249803

By Phone (for higher quality, dial a number based on your current location):
US: +1 669 900 6833  or +1 346 248 7799  or +1 312 626 6799  or
+1 646 558 8656  or +1 253 215 8782  or +1 301 715 8592
International numbers available: https://ucsf.zoom.us/u/abBh6VatYU

The session will be recorded for later play. See all past recordings.